CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Report for D013610: Tachycardia NIH

(Synonyms: Tachyc, Tachycar, Tachycard, Tachycardia)

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (6)


Name (Synonyms) Correlation
D016757 Death, Sudden, Cardiac NIH 1.00
D017180 Tachycardia, Ventricular NIH 1.00
D003643 Death, NIH 0.71
D007238 Infarction NIH 0.50
D009203 Myocardial Ischemia NIH 0.35
D020521 Stroke NIH 0.32

Correlated HPO Terms (5)


Name (Synonyms) Correlation
HP:0001649 Tachycardia HPO 1.00
HP:0004756 Ventricular tachycardia HPO 1.00
HP:0001645 Sudden cardiac death HPO 1.00
HP:0001658 Myocardial infarction HPO 0.35
HP:0001297 Stroke HPO 0.32

There is one clinical trial.

Clinical Trials


1 Acute Cardiovascular Events Triggered by COVID-19-Related, Non-infectious Stress The Jordan COVID-9 caRdiovascular Events (JoCORE) Study

The current COVID19 pandemic has afflicted almost the whole globe. The stress related to the pandemic, not the direct virus-related injury, can be potentially associated with acute cardiovascular events due to a large list of physical and psychosocial stresses. This study is a cross sectional study that will enroll patients evaluated during the COVID19 pandemic period for acute cardiovascular events.

NCT04368637 Acute Myocardial Infarction Ventricular Tachycardia Sudden Cardiac Death Stroke, Acute
MeSH:Stroke Myocardial Infarction Tachycardia Tachycardia, Ventricular Death, Sudden, Cardiac Infarction Death
HPO:Myocardial infarction Stroke Sudden cardiac death Tachycardia Ventricular tachycardia

Primary Outcomes

Description: Acute myocardial infarction as diagnosed by ST segment elevation or depression or inverted T wave on 12-lead EKG and elevated levels of cardiac troponins above the 99% of the normal values. A. Acute MI (STEMI and NSTEMI). B. Aborted on non-aborted sudden cardiac death not attributed to a known etiology. C. Sustained or non-sustained ventricular tachy-arrhythmia not attributed to a known etiology. D. ICD shocks. 3. Absence of suspected or confirmed infection with the COVID19 virus. 4. Definite physical or psycho-social stressful trigger appearing in relation to the COVID-19 situation (lock down stress, financial stress, anger, depression, fear, sorrow, death of a significant person, eating binges, smoking binges, physical stress [carrying walking for shopping and carrying excess weights] ..etc) as judged by a unanimous agreement of three investigators in the steering committee.

Measure: Acute cardiovascular event triggered by COVID-19 stress

Time: 4 months

Description: Typical ventricular tachycardia on 12-lead EKG or EKG monitor.

Measure: Ventricular tachycardia

Time: 4 months

Description: acute neurological symptoms of hemiparesis or dysrthria due to brain ischemia proven by computerized tomography or magnatic resonance

Measure: acute stroke

Time: 4 months

Description: Finding an episode of ventricular tachycardia on interrogation of ICD tracing

Measure: Implantable cardioverter defibrillator (ICD) shock

Time: 4 months


HPO Nodes